BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Eluri S, Shaheen NJ. Barrett's esophagus: diagnosis and management. Gastrointest Endosc. 2017;85:889-903. [PMID: 28109913 DOI: 10.1016/j.gie.2017.01.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 O’dowd D, O’sullivan J, Marcone S. Prognostic, Diagnostic and Predictive Biomarkers in the Barrett’s Oesophagus-Adenocarcinoma Disease Sequence. Cancers 2022;14:3427. [DOI: 10.3390/cancers14143427] [Reference Citation Analysis]
2 Moore J, Hekman R, Blum BC, Lawton M, Lehoux S, Stachler M, Pleskow D, Sawhney MS, Cummings RD, Emili A, Qureshi A. Pilot Study Showing Feasibility of Phosphoproteomic Profiling of Pathway-Level Molecular Alterations in Barrett’s Esophagus. Genes 2022;13:1215. [DOI: 10.3390/genes13071215] [Reference Citation Analysis]
3 Patel V, Ma S, Yadlapati R. Salivary biomarkers and esophageal disorders. Dis Esophagus 2022:doac018. [PMID: 35397479 DOI: 10.1093/dote/doac018] [Reference Citation Analysis]
4 Wilson BF, Dang J, Masuda D, Cowler T. Esophageal Adenocarcinoma in an Active Duty Sailor: A Case Report. Mil Med 2022:usac096. [PMID: 35355077 DOI: 10.1093/milmed/usac096] [Reference Citation Analysis]
5 Ramos RI, Cernadas G, Curvale C, Matano R. NORMAL VALUES OF ESOPHAGEAL 24-HOUR IMPEDANCE-PH AMBULATORY IN AN ARGENTINE COHORT OF HEALTHY VOLUNTEERS. Arq Gastroenterol 2022;59:47-52. [DOI: 10.1590/s0004-2803.202200001-09] [Reference Citation Analysis]
6 Pan W, Li X, Wang W, Zhou L, Wu J, Ren T, Liu C, Lv M, Su S, Tang Y. Identification of Barrett's esophagus in endoscopic images using deep learning. BMC Gastroenterol 2021;21:479. [PMID: 34920705 DOI: 10.1186/s12876-021-02055-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhao Z, Yin Z, Zhang C. Lifestyle interventions can reduce the risk of Barrett's esophagus: a systematic review and meta-analysis of 62 studies involving 250,157 participants. Cancer Med 2021;10:5297-320. [PMID: 34128354 DOI: 10.1002/cam4.4061] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Hanschmidt F, Treml J, Kreuser N, Gockel I, Kersting A. Anxiety and depression in patients with Barrett's esophagus: estimates of disorder rates and associations with symptom load and treatment-seeking. Eur J Gastroenterol Hepatol 2021;33:825-31. [PMID: 33136727 DOI: 10.1097/MEG.0000000000001960] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yan T, Wong PK, Qin YY. Deep learning for diagnosis of precancerous lesions in upper gastrointestinal endoscopy: A review. World J Gastroenterol 2021; 27(20): 2531-2544 [PMID: 34092974 DOI: 10.3748/wjg.v27.i20.2531] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
10 Ali S, Dmitrieva M, Ghatwary N, Bano S, Polat G, Temizel A, Krenzer A, Hekalo A, Guo YB, Matuszewski B, Gridach M, Voiculescu I, Yoganand V, Chavan A, Raj A, Nguyen NT, Tran DQ, Huynh LD, Boutry N, Rezvy S, Chen H, Choi YH, Subramanian A, Balasubramanian V, Gao XW, Hu H, Liao Y, Stoyanov D, Daul C, Realdon S, Cannizzaro R, Lamarque D, Tran-Nguyen T, Bailey A, Braden B, East JE, Rittscher J. Deep learning for detection and segmentation of artefact and disease instances in gastrointestinal endoscopy.Med Image Anal. 2021;70:102002. [PMID: 33657508 DOI: 10.1016/j.media.2021.102002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
11 Cummings D, Wong J, Palm R, Hoffe S, Almhanna K, Vignesh S. Epidemiology, Diagnosis, Staging and Multimodal Therapy of Esophageal and Gastric Tumors. Cancers (Basel) 2021;13:582. [PMID: 33540736 DOI: 10.3390/cancers13030582] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
12 Correia ACP, Straub D, Calpe S, Krishnadath KK. Novel In Vivo Mouse Cryoablation Model to Explore Unique Therapeutic Approaches for Premalignant Columnar Lesions. Methods Protoc 2021;4:6. [PMID: 33526760 DOI: 10.3390/mps4010006] [Reference Citation Analysis]
13 FalcÃo AM, Nasi A, Szachnowicz S, Santa-Cruz F, Seguro FCBC, Sena BF, Duarte A, Sallum RA, Cecconello I. Does the nissen fundoplication procedure improve esophageal dysmotility in patients with barrett's esophagus? Rev Col Bras Cir 2020;47:e20202637. [PMID: 33263652 DOI: 10.1590/0100-6991e-20202637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Xu Y, Tan Y, Wang Y, Gao J, Wu D, Xu X. A Gratifying Step forward for the Application of Artificial Intelligence in the Field of Endoscopy: A Narrative Review. Surg Laparosc Endosc Percutan Tech 2020;31:254-63. [PMID: 33122593 DOI: 10.1097/SLE.0000000000000881] [Reference Citation Analysis]
15 Dam AN, Klapman J. A narrative review of Barrett's esophagus in 2020, molecular and clinical update.Ann Transl Med. 2020;8:1107. [PMID: 33145326 DOI: 10.21037/atm-20-4406] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
16 Brosnan C, Hannan E, Duggan W, Harding T, Maguire D, Stafford AT. Diagnostic Inaccuracies of Barrett's Oesophagus on Gastroscopy: Are We Performing Unnecessary Surveillance? Cureus 2020;12:e9850. [PMID: 32953357 DOI: 10.7759/cureus.9850] [Reference Citation Analysis]
17 Wronska E, Polkowski M, Orlowska J, Mroz A, Wieszczy P, Regula J. Argon plasma coagulation for Barrett's esophagus with low-grade dysplasia: a randomized trial with long-term follow-up on the impact of power setting and proton pump inhibitor dose. Endoscopy 2021;53:123-32. [PMID: 32650347 DOI: 10.1055/a-1203-5930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
18 Kaibysheva V, Kashin S, Karasev A, Merkulova A, Krainova E, Fedorov E, Shapovalyants S. Update on Barrett’s esophagus diagnosis and treatment. Dok gastroenterol 2020;9:33. [DOI: 10.17116/dokgastro2020904133] [Reference Citation Analysis]
19 Iyer PG, Kaul V. Barrett Esophagus. Mayo Clinic Proceedings 2019;94:1888-901. [DOI: 10.1016/j.mayocp.2019.01.032] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
20 Okayasu I, Ichinoe M, Yoshida T. Proposal for an Organ-Specific Chronic Inflammation–Remodeling–Carcinoma Sequence. GastrointestDisord 2019;1:341-57. [DOI: 10.3390/gidisord1030028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Wallner B, Björ O, Andreasson A, Vieth M, Schmidt PT, Hellström PM, Forsberg A, Talley NJ, Agreus L. Z-line alterations and gastroesophageal reflux: an endoscopic population-based prospective cohort study. Scand J Gastroenterol 2019;54:1065-9. [PMID: 31453726 DOI: 10.1080/00365521.2019.1656775] [Reference Citation Analysis]
22 Alzoubaidi D, Graham D, Bassett P, Magee C, Everson M, Banks M, Novelli M, Jansen M, Lovat LB, Haidry R. Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett's esophagus-related neoplasia. Surg Endosc 2019;33:3665-72. [PMID: 30671663 DOI: 10.1007/s00464-018-06655-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
23 Lv J, Guo L, Wang JH, Yan YZ, Zhang J, Wang YY, Yu Y, Huang YF, Zhao HP. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett’s esophagus. World J Gastroenterol 2019; 25(2): 233-244 [PMID: 30670912 DOI: 10.3748/wjg.v25.i2.233] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
24 Klavan H, Russell MB, Macklin J, Lee E, Aslanian HR, Muniraj T. Barrett's esophagus: A comprehensive review for the internist. Dis Mon 2018;64:471-87. [PMID: 29880269 DOI: 10.1016/j.disamonth.2018.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Zhang C, Ma T, Luo T, Li A, Gao X, Wang ZG, Li F. Dysregulation of PARP1 is involved in development of Barrett’s esophagus. World J Gastroenterol 2018; 24(9): 982-991 [PMID: 29531462 DOI: 10.3748/wjg.v24.i9.982] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
26 Rumiato E, Boldrin E, Malacrida S, Realdon S, Fassan M, Morbin T, Battaglia G, Amadori A, Rugge M, Saggioro D. Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus. Translational Research 2017;190:16-24.e1. [DOI: 10.1016/j.trsl.2017.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
27 Fassan M, Facchin S, Munari G, Fanelli GN, Lorenzon G, Savarino E. Noncoding RNAs as drivers of the phenotypic plasticity of oesophageal mucosa. World J Gastroenterol 2017; 23(43): 7653-7656 [PMID: 29209106 DOI: 10.3748/wjg.v23.i43.7653] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]